New Opportunities, New Challenges: FDA Elaborates on use of Digital Health in Drug and Biological Product Development
This is Part 1 in a series of blog posts on developments from the U.S. Food and Drug Administration (“FDA”) regarding its commitments set forth under the Prescription Drug Under Fee Act...